Streetbeat News

Stock Prices

KIDS

OrthoPediatrics has reaffirmed its 2024 revenue guidance, projecting revenues between $200 million and $203 million.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:37 pm

GAIA

Gaia (NASDAQ:GAIA) reported Q2 2024 GAAP EPS of $(0.09), missing the $(0.05) estimate by 80%. Sales were $22.081M, missing the $22.400M estimate by 1.42%, but up 11.30% from last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:36 pm

CSX

CSX shares are trading higher after the company reported better-than-expected Q2 EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:36 pm

PLTR

Palantir Technologies Inc (NYSE:PLTR) reported strong Q2 earnings, with revenue and EPS beating estimates. Revenue grew 27% YoY, driven by a 55% increase in U.S. commercial revenue. The company raised its full-year 2024 outlook and expects significant growth in both commercial and government markets. Palantir's customer count increased 41% YoY. Shares were up 15.86% following the announcement.

Portfolio Pulse from Adam Eckert

August 05, 2024 | 8:36 pm

CBT

Cabot Corporation (NYSE:CBT) reported strong Q3 earnings, with adjusted EPS of $1.92 beating the estimate of $1.72 and sales of $1.02 billion surpassing the $1.00 billion estimate. This represents significant year-over-year growth in both earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:36 pm

IVAC

Intevac (NASDAQ:IVAC) reported better-than-expected Q2 2024 results with an adjusted EPS of $(0.12), beating the $(0.20) estimate, and sales of $14.526 million, surpassing the $8.300 million estimate. This represents significant improvements over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:35 pm

ETNB

89bio (NASDAQ:ETNB) reported a Q2 EPS loss of $(0.48), beating the analyst consensus estimate of $(0.57) by 15.79%. This represents a 7.69% improvement over the $(0.52) loss per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:34 pm

CRGY

Crescent Energy (NYSE:CRGY) reported Q2 2024 adjusted EPS of $0.50, significantly beating the analyst estimate of $0.28. The company also reported sales of $653.283 million, surpassing the $621.798 million estimate and marking a 32.69% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:34 pm

VMEO

Vimeo shares are trading higher following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:34 pm

BWXT

BWX Technologies has updated its 2024 adjusted EPS guidance, narrowing the range from $3.05-$3.20 to $3.10-$3.20, with an estimated EPS of $3.17.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 8:32 pm